Large Cell Neuroendocrine Carcinoma — Trials

Large Cell Neuroendocrine Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

24 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 15
Recruiting: 9
Ph III recruiting: 0
Growth YoY: —
Industry share: 40%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02709889	Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors	terminated	Phase 1 / Phase 2	200	AbbVieINDUSTRY	1	Oct 19, 2020	clinicaltrials

Data updated 23 days agoSource updated Oct 19, 2020source: clinicaltrials